Feng Yang

Dr. Feng Yang

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
YHYang Hu
Yang Hu
KJKuan Jiang
Kuan Jiang
DWDongli Wang
Dongli Wang
SYShengyu Yao
Shengyu Yao
LLLinwei Lu
Linwei Lu
GWGang Wei
Gang Wei

1 May 2012 in International Journal of Nanomedicine
Verified
Journal Article
Open access
YHYiping Hu
Yiping Hu
YWYe Wang
Ye Wang
XZXiao-Yuan Zi
Xiao-Yuan Zi
JSJuan Su
Juan Su
HZHong-Xia Zhang
Hong-Xia Zhang
FYFeng Yang
Feng Yang
Peer reviewed article authored by (Wang Y, Zi XY, Su J, Zhang HX, Zhang XR, Zhu HY, Li JX, Yin M, Yang F, Hu YP.). Read article or submit your manuscript for publishing.

9 August 2022 in Nano Letters
Verified
Journal Article
Closed access
HWHuan Wang
Huan Wang
SLShiqi Lin
Shiqi Lin
SWSongli Wang
Songli Wang
ZJZhuxuan Jiang
Zhuxuan Jiang
TDTianhao Ding
Tianhao Ding
CZChangyou Zhan
Changyou Zhan

18 February 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
GSGuangze Sang
Guangze Sang
BWBingkai Wang
Bingkai Wang
YXYujie Xie
Yujie Xie
Yu ChenYu Chen
Yu Chen
FYFeng Yang
Feng Yang
Inflammatory bowel disease (IBD) is a chronic condition affecting the intestines, marked by immune-mediated inflammation. This disease is known for its recurrent nature and the challenges it presents in treatment. Recently, probiotic have gained attention as a promising alternative to traditional small molecular drugs and monoclonal antibody chemotherapies for IBD. Probiotic, recognized as a “living” therapeutic agent, offers targeted treatment with minimal side effects and the flexibility for biological modifications, making them highly effective for IBD management. This comprehensive review presents the latest advancements in engineering probiotic-based materials, ranging from basic treatment mechanisms to the modification techniques used in IBD management. It delves deep into how probiotic produces therapeutic effects in the intestinal environment and discusses various strategies to enhance probiotic's efficacy, including genetic modifications and formulation improvements. Additionally, the review addresses the challenges, practical application conditions, and future research directions of probiotic-based therapies in IBD treatment, providing insights into their feasibility and potential clinical implications.

1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
JZJieqiong Zhan
Jieqiong Zhan
ZMZhiqiang Ma
Zhiqiang Ma
DWDan Wang
Dan Wang
XLXinfang Li
Xinfang Li
XLXiangui Li
Xiangui Li
FYFeng Yang
Feng Yang
Nonspecific targeting, large doses and phototoxicity severely hamper the clinical effect of photodynamic therapy (PDT). In this work, superparamagnetic Fe3O4 mesoporous silica nanoparticles grafted by pH-responsive block polymer polyethylene glycol-b-poly(aspartic acid) (PEG-b-PAsp) were fabricated to load the model photosensitizer rose bengal (RB) in the aim of enhancing the efficiency of PDT. Compared to free RB, the nanocomposites (polyethylene glycol-b-polyaspartate-modified rose bengal-loaded magnetic mesoporous silica [RB–MMSNs]) could greatly enhance the cellular uptake due to their effective endocytosis by mouse melanoma B16 cell and exhibited higher induced apoptosis although with little dark toxicity. RB–MMSNs had little dark toxicity and even much could be facilitated by magnetic field in vitro. RB–MMSNs demonstrated 10 times induced apoptosis efficiency than that of free RB at the same RB concentration, both by cell counting kit-8 (CCK-8) result and apoptosis detection. Furthermore, RB–MMSNs-mediated PDT in vivo on tumor-bearing mice showed steady physical targeting of RB–MMSNs to the tumor site; tumor volumes were significantly reduced in the magnetic field with green light irradiation. More importantly, the survival time of tumor-bearing mice treated with RB–MMSNs was much prolonged. Henceforth, polyethylene glycol-b-polyaspartate-modified magnetic mesoporous silica (MMSNs) probably have great potential in clinical cancer photodynamic treatment because of their effective and low-toxic performance as photosensitizers’ vesicles.

1 July 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
ZMZhiqiang Ma
Zhiqiang Ma
PHPengwei Hu
Pengwei Hu
CGChangyong Guo
Changyong Guo
DWDan Wang
Dan Wang
XZXingjie Zhang
Xingjie Zhang
FYFeng Yang
Feng Yang
Background: Nonspecific tumor targeting, potential relapse and metastasis of tumor after treatment are the main barriers in clinical photodynamic therapy (PDT) for cancer, hence, inhibiting relapse and metastasis of tumor is significant issues in clinic. Purpose: In this work, chidamide as a histone deacetylases inhibitor (HADCi) was bound onto a pH-responsive block polymer folate polyethylene glycol-b-poly(aspartic acid) (PEG-b-PAsp) grafted folate (FA-PEG-b-PAsp) to obtain the block polymer folate polyethylene glycol-b-poly(asparaginyl-chidamide) (FA-PEG-b-PAsp-chidamide, FPPC) as multimodal tumor-targeting drug-delivery carrier to inhibiting tumor cell proliferation and tumor metastasis in mice. Methods: Model photosensitizer pyropheophorbide-a (Pha) was encapsulated by FPPC in PBS to form the polymer micelles [email protected] [folate polyethylene glycol-b-poly(asparaginyl-chidamide) micelles encapsulating Pha]. [email protected] was characterized by transmission electron microscope and dynamic light scattering; also, antitumor activity in vivo and in vitro were investigated by determination of cellular ROS level, detection of cell apoptosis and cell cycle arrest, PDT antitumor activity in vivo and histological analysis. Results: With favorable and stable sphere morphology under transmission electron microscope (TEM) (∼93.0 nm), [email protected] greatly enhanced the cellular uptake due to its folate-mediated effective endocytosis by mouse melanoma B16-F10 cells and the yield of ROS in tumor cells induced by PDT, and mainly caused necrocytosis and blocked cell growth cycle not only in G2 phase but also in G1/G0 phase after PDT. [email protected] exhibited lower dark cytotoxicity in vitro and a better therapeutic index because of its higher dark cytotoxicity/photocytotoxicity ratio. Moreover, [email protected] not only significantly inhibited the growth of implanted tumor and prolonged the survival time of melanoma-bearing mice due to both its folate-mediated tumor-targeting and selectively accumulation at tumor site by EPR (enhanced permeability and retention)effect as micelle nanoparticles but also remarkably prevented pulmonary metastasis of mice melanoma after PDT compared to free Pha, demonstrating its dual antitumor characteristics of PDT and HDACi. Conclusion: As a folate-mediated and acid-activated chidamide-grafted drug-delivery carrier, FPPC may have great potential to inhibit tumor metastasis in clinical photodynamic treatment for cancer because of its effective and multimodal tumor-targeting performance as photosensitizer vehicle.